Client News

Roquefort Therapeutics PLC: Director/PDMR Shareholding
Home / Client News / Roquefort Therapeutics PLC: Director/PDMR Shareholding

Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, advises that Stephen West, Executive Chairman has purchased ordinary shares in the Company in the market.

Please follow the link below for more information:

https://www.londonstockexchange.com/news-article/ROQ/director-pdmr-shareholding/15525313

OPEN AN ACCOUNT

If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.

CLIENT AREA

Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.

Share This